Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
Miller
Donald R
DR
D000932:Antiemetics / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001281:Atrial Fibrillation / Q000139:chemically induced; D004329:Droperidol / Q000009:adverse effects; D004562:Electrocardiography; D006801:Humans; D007211:Indoles / Q000009:adverse effects; D017294:Ondansetron / Q000009:adverse effects; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D011807:Quinolizines / Q000009:adverse effects
D000932:Antiemetics; D007211:Indoles; D011807:Quinolizines; D017294:Ondansetron; C060344:dolasetron; D004329:Droperidol